First isolated from human gastric juice in 1993 by Croatian researchers, this 15-amino acid peptide demonstrates remarkable tissue-protective properties across multiple organ systems
How to Use Application Apply one patch to a clean, hairless area on your shoulder, back, or hip
Phase 3 results (TRIUMPH-4, 68 weeks) The Phase 3 TRIUMPH-4 trial evaluated 9mg and 12mg doses over 68 weeks in adults with obesity and knee osteoarthritis
Chronically shifting your injection earlierinjecting every 56 days instead of weeklycan disrupt the steady-state concentration that produces optimal appetite control
An insulin syringe, the standard U-100 type used for subcutaneous injections, divides each milliliter into 100 units
Possible mild side effects may include slight redness, swelling, or tenderness at the injection site , as well as temporary headaches or fatigue